Patty Cason, MSN, FNP-BC, President, Envision SRH
Michael Policar, MD, MPH, Professor Emeritus, University of California, San Francisco
The 2019 ASCCP Guidelines are substantially different from earlier versions and reflect increased understanding of the natural history of HPV infections and progression to high grade lesions. Management recommendations for the new guidelines were updated based on data from significantly larger databases than were previously available. Six “clinical action thresholds” are presented that form the basis for the recommendations. The clinical action thresholds are derived from the calculated risk, based on current and past test results, that the individual will have or develop a high grade/pre-cancerous lesion. We will highlight the significant revisions to the 2019 ASCCP Guidelines and share practical tips for implementation of the guidelines in practice. Participants will practice with the new ASCCP mobile APP and the APP that is free on the ASCCP website for management recommendations.